When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MREO - Mereo Bio up 19% premarket on new setrusumab data
Mereo BioPharma Group
Thinly traded nano cap Mereo BioPharma Group plc (NASDAQ:MREO) is up 19% premarket on modest volume in reaction to additional data from a Phase 2b clinical trial, ASTEROID, evaluating setrusumab (BPS-804) in adults with Type I, III or IV osteogenesis imperfecta, also known as brittle bone disease. Topline results were first announced in November 2019.
More news on: Mereo BioPharma Group plc, Healthcare stocks news, Stocks on the move,